CLINICAL PRACTICE GUIDELINES Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, The Netherlands; Department of Gastroenterology, Kremlin Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Department of Medicine, Dermatology Unit, Gustave Roussy Cancer Campus, Villejuif, France; Department of Pathology, Aberdeen University Medical School & Aberdeen Royal Infirmary, Aberdeen, UK; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; Royal Marsden Hospital NHS Foundation Trust, London, UK; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital of Heidelberg, Heidelberg, Germany